Out-of-hours antibiotic prescription after screening with C reactive protein: A randomised controlled study by Rebnord, Ingrid Keilegavlen et al.
Out-of-hours antibiotic prescription
after screening with C reactive protein:
a randomised controlled study
Ingrid Keilegavlen Rebnord,1,2 Hogne Sandvik,1 Anders Batman Mjelle,3
Steinar Hunskaar1,2
To cite: Rebnord IK,
Sandvik H, Batman Mjelle A,
et al. Out-of-hours antibiotic
prescription after screening
with C reactive protein:
a randomised controlled
study. BMJ Open 2016;6:
e011231. doi:10.1136/
bmjopen-2016-011231
▸ Prepublication history for
this paper is available online.
To view these files please
visit the journal online
(http://dx.doi.org/10.1136/
bmjopen-2016-011231).
Received 21 January 2016
Revised 5 April 2016
Accepted 26 April 2016







Objective: To evaluate the effect of preconsultation C
reactive protein (CRP) screening on antibiotic prescribing
and referral to hospital in Norwegian primary care
settings with low prevalence of serious infections.
Design: Randomised controlled observational study at
out-of-hours services in Norway.
Setting: Primary care.
Participants: 401 children (0–6 years) with fever and/or
respiratory symptoms were recruited from 5 different out-
of-hours services (including 1 paediatric emergency
clinic) in 2013–2015.
Intervention: Data were collected from questionnaires
and clinical examination results. Every third child was
randomised to a CRP test before the consultation; for the
rest, the doctor ordered a CRP test if considered
necessary.
Outcome measures: Main outcome variables were
prescription of antibiotics and referral to hospital.
Results: In the group pretested with CRP, the antibiotic
prescription rate was 26%, compared with 22% in the
control group. In the group pretested with CRP, 5% were
admitted to hospital, compared with 9% in the control
group. These differences were not statistically significant.
The main predictors for ordering a CRP test were
parents’ assessment of seriousness of the illness and the
child’s temperature. Paediatricians ordered CRP tests less
frequently than did other doctors (9% vs 56%, p<0.001).
Conclusions: Preconsultation screening with CRP of
children presenting to out-of-hours services with fever
and/or respiratory symptoms does not significantly affect
the prescription of antibiotics or referral to hospital.
Trial registration number: NCT02496559; Results.
INTRODUCTION
Fever, respiratory symptoms and infections
are common among children in primary
care, especially at out-of-hours (OOH) ser-
vices.1 Serious infections have low prevalence
in primary care, and even more so after
introduction of vaccines for Haemophilus
influenzae type B and pneumococcal conju-
gate vaccines.2 3 It is challenging for clini-
cians to distinguish serious and low-prevalent
diseases from common, self-limiting infec-
tions. A severity-of-illness scoring system does
not exist for primary care.
In Norway, 85% of antibiotics are pre-
scribed in primary care.4 Despite a decrease
in serious infections, the use of antibiotics
has been increasing until 2012, and is gener-
ally believed to be unnecessarily widespread.5
Although there has been an increase in
methicillin-resistant Staphylococcus aureus
(MRSA), the prevalence of antibiotic resist-
ant bacteria is lower than in most other
countries.6 In order to keep the antimicro-
bial resistance low, it is important to avoid
unnecessary antibiotics and use narrow spec-
trum penicillin when possible.7
C reactive protein (CRP) is an inflamma-
tion marker, reflecting the severity of inflam-
mation and tissue injury, which is used as a
tool to differentiate between bacterial and
viral infections.8 It has high popularity in
Norwegian primary care as a point-of-care
test, and in OOH services it is used in more
than half of all children with respiratory
symptoms.1 9 It thus seems that CRP testing
is more like a routine, rather than a supple-
ment to history taking and clinical
examination.
Strengths and limitations of this study
▪ The study is a randomised controlled trial evalu-
ating the effect on antibiotic prescription and
hospital referral by screening children with fever
and/or respiratory symptoms with a C reactive
protein (CRP) test before the consultation.
▪ Nearly complete data since we used dedicated
nurses to collect clinical symptoms and findings
on all children.
▪ The study was underpowered, that is, the differ-
ences were too small to reach statistical
significance.
▪ Identified predictors of CRP testing are observa-
tional and not a result of the randomised trial.
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The CRP test’s role in ruling out or ruling in serious
infections, and the cut-off value for when to prescribe
antibiotics, have been widely discussed.8 10 The impact
of CRP as a way of reducing the number of antibiotic
prescriptions is at best unclear.11–16
The aim of the present study was to evaluate the effect
of preconsultation screening with CRP on antibiotic
prescribing and referral to hospital for children aged
0–6 years presenting at OOH services with fever and/or
respiratory symptoms.
METHOD
We designed a randomised controlled observational
study including children aged 0–6 years with fever or any
respiratory symptoms. The data consist of clinical symp-
toms and signs collected by a nurse at the OOH services
before the doctor’s consultation, a questionnaire filled
in by the parents before the consultation, and the
medical record. Every third child was randomised to a
CRP test before the consultation with a predefined mark
in their study folder. The remaining 2/3 received usual
care, allowing the doctor to order a CRP test on individ-
ual indication. Other tests also available were rapid strep
test, urine dipstick test, haemoglobin and glucose.
Inclusion and procedures
The inclusion of participants took place during the winter
seasons from January 2013 to May 2015 at four different
OOH services near Bergen and at one paediatric emer-
gency clinic at Haukeland University Hospital in Bergen.
This emergency clinic is a walk-in, open access facility, and
it is located at a hospital and staffed by paediatricians.
The nurses at the OOH services were trained in the
study inclusion criteria and examination procedures. At
the paediatric emergency clinic, two trained nurses were
engaged specially for the project. The parents were
approached by the nurse and invited to participate in
the study and fill out a questionnaire prior to the con-
sultation. The nurse did a clinical examination of all
children and a CRP test of every child randomised to
the test. The CRP result followed the patient to the con-
sultation but not the study folder with the results from
the questionnaire. The diagnosis and treatment were
recorded from the medical record after the consult-
ation. Numbers of potential patients not asked or
approached were not recorded.
Variables
The two main outcome variables were antibiotic pre-
scription and referral to hospital. Recorded variables
from the medical history were age, gender, previous
chronic disease, duration of present illness, fever during
the past 24 h, variation in fever, vomiting, earache,
coughing, dyspnoea, throat symptoms, diarrhoea,
reduced diuresis, cervical rigidity, skin rash and use of
paracetamol or ibuprofen during the past 24 h. The
parents’ assessment of the illness and its seriousness was
also recorded. Variables from the nurse’s examination
were temperature, respiratory rate, oxygen saturation,
degree of hydration, capillary refill time and general
condition on a three-point scale (normal, ill and severely
ill). Finally, we recorded whether the doctor was a
paediatrician or working at the OOH services.
Study sample calculation
A power calculation was based on the following pre-
sumptions: we presumed that 35% of all children would
receive antibiotic treatment based on data from earlier
studies,17 18 and that CRP would be requested in every
second consultation.1 Furthermore, we presumed that
the doctor requested a CRP for the most seriously ill
children and that 50% of these children would receive
antibiotics, compared with 20% for the healthier non-
tested group. The null hypothesis was that pretested
CRP would not change the frequency of antibiotic treat-
ment, that is, 35% of both groups would receive antibio-
tics. If a 40% change (effect size) in antibiotic treatment
due to pretested CRP was defined as significant, using a
two-sided test, power 80%, α level 5%, the sample sizes
would have to be 130+259. If effect size was reduced
from 40% to 20%, the sample sizes would have to be
525+1050. As it turned out, recruiting participants was
challenging, and an interim analysis was performed
when 400 children were included. The difference in
antibiotic prescriptions was much smaller than what we
considered clinically significant, and we therefore
decided to stop further recruitment of participants.
Statistical analysis
Proportions were compared by χ2 tests, means by
Student’s t tests. A logistic regression analysis was per-
formed to analyse predictors for ordering a CRP.
Explanatory variables that were significant in bivariate
analyses were included in the final model. The signifi-
cance level was set at 5% (p<0.05). Data were analysed
using IBM SPSS (V.21).
RESULTS
A total of 401 children were included in the study, but
four left the clinic before the doctor’s consultation,
leaving 397 for inclusion in our analyses (figure 1). A
comparison of the two randomised groups is shown in
table 1. The mean age was 2.3 years, and 223 (55.6%)
were boys. The mean duration of illness was 6.5 days and
the mean temperature at the consultation was 38.0°C.
No significant differences were found, except that the
general condition was more often assessed as normal in
the group randomised to a CRP test. A similar compari-
son of children attending OOH services and the hospital
clinic showed that those at the hospital clinic had a sig-
nificantly lower temperature, respiratory rate, higher
oxygen saturation, reported less use of paracetamol, and
were assessed to be in better general condition than
those at the OOH services (table 1).
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A rapid strep test was taken in seven cases; all were
negative, but three of the children got a prescription of
antibiotics. A urine dipstick test was performed in three
cases and two of the children were diagnosed with
pyelonephritis.
In total, 93 (23%) received a prescription for antibio-
tics and 31 (8%) were admitted to hospital. In the group
pretested with CRP, the antibiotic prescription rate was
26%, compared with 22% in the control group. In the
group pretested with CRP; 5% were admitted to hospital,
compared with 9% in the control group (table 2).
The mean result of pretested CRP was significantly
lower than when requested by the doctor (21 vs 34 mg/L,
p=0.006). Paediatricians ordered CRP tests less frequently
than did other doctors (9% vs 56%, p<0.001).
In the logistic regression analyses, three variables
remained significantly associated with ordering a CRP
test. Use of CRP increased if the parents thought their
child had a serious infection or if the child had a high
temperature at the consultation. Use of CRP decreased
if the doctor was a paediatrician (table 3).
Upper respiratory infection was the most frequently
used diagnosis, followed by otitis media and tonsillitis
(table 4). Antibiotic prescription rate was highest with
tonsillitis (68%) and otitis media/pneumonia (67%). All
patients with pneumonia not given antibiotics were
referred to hospital (33%). Pyelonephritis, dehydration,
bronchiolitis and fever of unknown origin were the
other most frequent reasons for referral to hospital.
DISCUSSION
Summary
In this randomised controlled study of preconsultation
CRP testing of children with fever and/or respiratory
symptoms, no significant effect was found on antibiotic
prescription or hospital admittance. The study confirms
that CRP tests are widely used in OOH services and the
excessive use rather tends to increase the antibiotic pre-
scription than to reduce it. High fever and concerned
parents predict CRP testing. Paediatricians order CRP
testing less frequently than do OOH doctors.
Strengths and limitations
Our data, according to protocol, are nearly complete
due to the effort of the nurses. Collecting data from the
medical record only would have been simpler and
maybe increased the number of included children, but
would probably have caused more missing data.
The inclusion was challenging since the nurses at the
OOH services had to ask and inform the parents to par-
ticipate, interview them and do some tests before the
consultation, all this on top of their normal job. The
study inclusion may have been given a lower priority on
busy days. At the paediatric emergency clinic, we used a
dedicated study nurse who was able to include all chil-
dren for whom the parents consented.
The children who are seen by a paediatrician at the
paediatric emergency clinic are unselected and not
referred from primary care. At the OOH services, the
doctor is a general practitioner (GP), a GP in training
or locums. We have no detailed information about the
experience of these OOH doctors but know that
younger doctors are working more often OOH and use
more CRP.9 19 How the experience affects the prescrip-
tion is not known. The paediatric emergency clinic had
the function as an OOH service for children in Bergen
city, but the children at the clinic seemed to be slightly
healthier, maybe due to the walk-in, open access facility.
At the other OOH services, the parents had to call first
for advice and only got an appointment if the child was
assessed to need a doctor consultation.20 This differ-
ence may have influenced the use of CRP tests and pre-
scription of antibiotics. Doctors at the OOH services
get an extra fee for each CRP test, while there is no
such economic incentive at the paediatric emergency
clinic. This may explain some of the difference in use
of CRP tests.
The study was not blinded and knowledge about the
purpose of the study may have influenced the doctor’s
prescription pattern. However, this influence would
probably affect both groups equally.
One main limitation is the study sample, which was
estimated from an expectation that preconsultation CRP
Figure 1 Flow chart over included and investigated patients
in the study. CRP, C reactive protein; OOH, out-of-hours.
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screening would affect antibiotic prescription to a larger
degree than what turned out to be true. If the differ-
ences found were to be statistically significant, the study
sample would have to be several times larger. The
number of referrals to hospital was small in this study
and it is not possible to state from these data if screening
with CRP affects it. Other laboratory tests (rapid strep
test and urine dipstick) were used little.
Comparison with the existing literature
Children with fever and/or respiratory symptoms are fre-
quent attenders at OOH services, but to compare the
distribution of diagnoses is difficult because of the
different diagnostic criteria and different precision level.
In our material, there were a lot of symptom diagnoses,
such as fever, cough, viral illness, upper respiratory infec-
tion, etc. This reflects how difficult it is to give a valid
diagnosis in primary care. A high CRP result may indi-
cate a more severe diagnosis, such as pneumonia, but
rarely these diagnoses are validated in other ways
(X-rays, sputum samples, etc).
In one study from general practice in the UK, includ-
ing children aged <5 years with acute illness,21 lower
respiratory infections were more common, and tonsillitis
and ear infections less common than in our study. The
antibiotic prescription rate was higher for all diagnoses,
Table 1 Comparison of background variables in the two randomised groups and the two different clinical settings

















Mean (SD) 2.13 (1.7) 2.44 (1.9) 0.104 2.38 (1.7) 2.29 (1.9) 0.638
Median (IQR) 1.5 (0.9–2.9) 1.9 (1.0–3.5) 1.9 (1.0–3.5) 1.5 (0.9–3.0)
Duration illness (day)
Mean (SD) 7.0 (11.0) 6.4 (7.7) 0.434 6.0 (7.7) 7.2 (9.9) 0.175
Median (IQR) 4 (3–7) 4 (2–7) 4 (2–7) 4 (2–7)
Temperature (°C)










Mean (SD) 34.2 (15.0) 31.8 (12.7) 0.118 34.0 (13.4) 30.9 (13.6) 0.028
Median (IQR) 30 (20–42) 28 (20–40) 31 (22–44) 25 (20–38)
Earache 24.4 27.4 0.566 26.3 26.3 0.955
Cough 86.1 84.0 0.665 85.1 84.8 0.987
Dyspnoea 61.6 54.4 0.098 60.0 52.6 0.090
Diarrhoea 19.1 18.6 0.657 18.9 18.7 0.963
Taken paracetamol during the past
24 h
65.9 66.5 0.783 73.4 57.3 0.001
Gender (male) 53.6 56.7 0.502 57.8 52.6 0.370
General condition
Normal 29.0 20.1 0.052 18.3 29.2 0.003
Ill 68.8 76.8 77.8 69.6
Severely ill 2.2 2.7 3.5 1.2
Pulse oximetry
>95% 53.6 58.7 0.181 51.7 63.2 0.002
90–95% 29.0 24.3 30.0 20.5
<90% 2.9 1.9 3.5 0.6
Earlier experienced CRP
Yes 69.6 71.5 0.800 76.9 63.2 0.109
No 2.2 1.5 0.9 2.9
Do not know 18.8 20.2 22.3 22.2
Chronic disease
No disease 75.4 74.1 0.851 74.3 74.3 0.948
Asthma 18.1 20.8 21.3 18.1
Allergy/other 6.5 5.0 4.4 7.6
Consultation with paediatrician 42.8 42.6 0.840 0.0 100.0
Numbers are proportions (%) otherwise stated.
*p Values from comparison of means and proportions in the intervention groups, using Student’s t tests and non-parametric tests.
†p Values from comparison of means and proportions in the different clinical settings, using Student’s t tests and non-parametric tests.
CRP, C reactive protein; OOH, out-of-hours.
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with a total prescription rate of 26% compared with
23% in our study. In two Dutch studies from OOH ser-
vices, the prescription rate was 36% and 37% for febrile
children;22 23 in a comparable study from paediatric out-
patient settings in Sweden and Estonia, the prescription
rate was 35% and 61%.24
In a comparable study from Norwegian general prac-
tice, the total antibiotic prescription rate was 26%, but
for otitis media it was only 42% compared with 67% in
our study.25 For pneumonia and tonsillitis, the prescrip-
tion rates were more similar, 71% and 79%, compared
with 67% for both in our study. It seems that the pre-
scription rates in our study were rather low compared
with other countries, but correspond well with earlier
published Norwegian results. Norway still seems to be a
low-prescription country.
The use of CRP at OOH services in Norway is high
compared with other countries. In our study, CRP was
ordered in 56% of consultations at the OOH services. In
a Swedish study, CRP was ordered in 36% of all consulta-
tions.26 Another recently published Swedish study where
both children and adults were included found CRP
Table 2 Effect of preconsultation screening with CRP on the rate of antibiotic prescription and referral to hospital
Intervention group CRP
pretested










(95% CI) p Value
All children n=397 n=138 n=259
Prescription of antibiotics 36 26 (19 to 34) 57 22 (17 to 27) 0.361
Referral to hospital 7 5 (1 to 9) 24 9 (6 to 13) 0.138
OOH services n=230 n=79 n=151
Prescription of antibiotics 25 32 (21 to 42) 38 25 (18 to 32) 0.295
Referral to hospital 4 5 (0 to 10) 12 8 (4 to 12) 0.414
Paediatric emergency clinic n=167 n=59 n=108
Prescription of antibiotics 11 19 (8 to 29) 19 18 (10 to 25) 0.866
Referral to hospital 3 5 (−1) to 11) 12 11 (5 to 17) 0.193
CRP, C reactive protein; OOH, out-of-hours.
Table 3 OR for ordering a CRP test in the group randomised to CRP at request, n=259
Variable CRP requested % OR CI (95%) p Value
Parents’ assessment of sickness
No opinion n=110 44 Ref.
Viral infection n=69 25 0.51 0.16 to 1.59 0.248
Bacterial infection n=79 35 0.84 0.32 to 2.24 0.734
Parents’ assessment of degree of seriousness
Think it is not serious but want a check n=66 17 Ref.
Not sure, maybe in need of treatment n=97 42 4.99 1.77 to 14.03 0.002
Think antibiotics are needed n=89 40 5.80 1.88 to 17.92 0.002
Think the child needs hospitalisation n=6 100 NC
Respiratory rate* 1.01 0.97 to1.04 0.768
Temperature (°C)* 1.64 1.08 to2.48 0.019
Use of paracetamol during the past 24 h
No n=84 24 Ref.
Yes n=173 42 1.43 0.59 to 3.42 0.428
Fever during the past 24 h
No n=35 11 Ref.
Yes n=224 40 2.95 0.53 to 16.35 0.215
General condition
Normal n=52 21 Ref.
Ill n=199 40 1.52 0.57 to 3.98 0.399
Severely ill n=7 71 1.30 0.14 to 12.02 0.817
Type of doctor
Paediatric emergency clinic n=108 56 Ref.
Out-of-hours services n=151 9 15.65 6.06 to 40.43 <0.001
Multiple logistic regression analysis.
*Continuous variables.
CRP, C reactive protein; NC, not calculated; Ref., reference.
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testing in 38% and that CRP pretesting correlated with
increased antibiotic prescription.27
The effect of CRP testing on antibiotic prescription
has been studied in several settings, with conflicting
results. For adult patients, no effect was found for acute
bronchitis28 or acute pharyngitis.14 However, in other
studies of respiratory tract infections, CRP testing has
resulted in lower prescription rates.15 16 29 For children,
there are fewer studies, but one systematic review from
2011 analysed which CRP values that could be diagnos-
tically useful when trying to rule in or rule out serious
infections.10 Another study that included clinical signs
and CRP in a prediction model found it useful for esti-
mating pneumonia and other serious bacterial infec-
tions.30 Common for most other studies that look at the
effect CRP testing has on antibiotic prescription, is that
CRP is used as an intervention in settings where CRP
rarely is used. In contrast, we have studied what happens
in a low-prevalent population, where CRP is easily access-
ible, where normal practice and economic incentives
stimulate to use CRP very often.
Implications for research and practice
Antibiotic prescription rates in Norway are relatively low
compared with other countries, but still higher than
recommended, and many prescriptions do not follow
the national guidelines for antibiotic prescription.7 The
extensive use of CRP in Norway and a tendency towards
screening every febrile child with a CRP test, often
before the consultation, is not according to any recom-
mendations. There is no evidence for benefit of this
practice. Our study shows that CRP screening does not
reduce antibiotic prescription rates; the trend is rather
an increase. Possibly, prescription rates are increased
due to more often false positive CRP values when the
test is taken so often at children with low risk of serious
infections. Training in communication skills may affect
prescription rates,29 and should be given priority over
extensive laboratory testing in this setting.
Widespread use of antibiotics for otitis media and ton-
sillitis, such as found in our study, is not recommended
according to the national guidelines. The same goes for
antibiotic prescriptions for unspecific diagnoses such as
cough and upper respiratory infections.
Further studies should focus on how to reduce clini-
cians’ uncertainty with the use of clinical prediction
rules validated for low-prevalent populations, and train-
ing in communication skills to reduce parents’ concern.
CONCLUSION
CRP is extensively used in children at Norwegian OOH
services, especially when the child has high fever, or if
the parents think it is a serious infection. CRP screening
of all children with fever and/or respiratory infections
will not reduce the prescription of antibiotics.
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Table 4 Distribution of diagnoses, how often CRP is taken on request, CRP values, antibiotic prescription, and referral to


























Acute tonsillitis 47 32 29 45 68 0
Otitis media 54 40 22 26 67 0
Pneumonia 15 80 49 86 67 33
URI 128 34 15 34 5 2
Viral infection 31 28 21 16 3 3
Fever 20 50 9 54 0 15
Laryngitis 17 12 16 19 6 12
Bronchiolitis 16 10 16 – 0 56
Respiratory infection 13 50 27 16 15 0
Cough 12 55 7 21 8 8
Asthma 8 17 5 5 12 12
Bronchitis 7 50 5 11 42 29
Influenza 5 0 5 – 0 20
Gastroenteritis 5 50 28 – 0 40
Pyelonephritis 2 100 – 91 0 100
Other 17 0 14 11 0 0
CRP, C reactive protein; URI, upper respiratory infection.
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